近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Activation induced cell death (AICD) of human melanoma antigen-specific TCR engineered CD8 T cells involves JNK, Bim and p53. Chhabra, Arvind; Mukherji, Bijay; Batra, Deepika Expert opinion on therapeutic targets 2016 Dec;1-13
Suppression of inducible CD4 regulatory cells by MHC class I-restricted human tumor epitope specific TCR engineered multifunctional CD4 T cells. Chhabra, Arvind; Mukherji, Bijay Human immunology 2016 Jun;
Knockdown of T-bet expression in Mart-127-35 -specific T-cell-receptor-engineered human CD4(+) CD25(-) and CD8(+) T cells attenuates effector function. Jha, Sidharth S; Chakraborty, Nitya G; Singh, Prashant; Mukherji, Bijay; Dorsky, David I Immunology 2014 Dec;145(1):124-35
Death receptor-independent activation-induced cell death in human melanoma antigen-specific MHC class I-restricted TCR-engineered CD4 T cells. Chhabra, Arvind; Mukherji, Bijay Journal of immunology (Baltimore, Md. : 1950) 2013 Sep;191(6):3471-7
Metastatic melanoma in the older patient: immunologic insights and treatment outcomes. Hegde, Upendra P; Chakraborty, Nitya; Mukherji, Bijay; Grant Kels, Jane M Expert review of pharmacoeconomics & outcomes research 2011 Apr;11(2):185-93
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro. Ray, Swagatam; Chhabra, Arvind; Chakraborty, Nitya G; Hegde, Upendra; Dorsky, David I; Chodon, Thinle; von Euw, Erika; Comin-Anduix, Begonya; Koya, Richard C; Ribas, Antoni; Economou, James S; Rosenberg, Steven A; Mukherji, Bijay Clinical immunology (Orlando, Fla.) 2010 Sep;136(3):338-47
The oxazolidinone derivative locostatin induces cytokine appeasement. Ménoret, Antoine; McAleer, Jeremy P; Ngoi, Soo-Mun; Ray, Swagatam; Eddy, Nicholas A; Fenteany, Gabriel; Lee, Seung-Joo; Rossi, Robert J; Mukherji, Bijay; Allen, David L; Chakraborty, Nitya G; Vella, Anthony T Journal of immunology (Baltimore, Md. : 1950) 2009 Dec;183(11):7489-96
Inhibition of superoxide generation upon T-cell receptor engagement rescues Mart-1(27-35)-reactive T cells from activation-induced cell death. Norell, H?kan; Martins da Palma, Telma; Lesher, Aaron; Kaur, Navtej; Mehrotra, Meenal; Naga, Osama S; Spivey, Natalie; Olafimihan, Seye; Chakraborty, Nitya G; Voelkel-Johnson, Christina; Nishimura, Michael I; Mukherji, Bijay; Mehrotra, Shikhar Cancer research 2009 Aug;69(15):6282-9
Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma. Ray, Swagatam; Chhabra, Arvind; Mehrotra, Shikhar; Chakraborty, Nitya G; Ribas, Antoni; Economou, James; Mukherji, Bijay Clinics in dermatology 2009 Jan;27(6):603-13
CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model. Chhabra, Arvind; Yang, Lili; Wang, Pin; Comin-Anduix, Bego?a; Das, Raja; Chakraborty, Nitya G; Ray, Swagatam; Mehrotra, Shikhar; Yang, Haiguang; Hardee, Cinnamon L; Hollis, Roger; Dorsky, David I; Koya, Richard; Kohn, Donald B; Ribas, Antoni; Economou, James S; Baltimore, David; Mukherji, Bijay Journal of immunology (Baltimore, Md. : 1950) 2008 Jul;181(2):1063-70
Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-1 27-35. Chhabra, Arvind; Chakraborty, Nitya G; Mukherji, Bijay Clinical immunology (Orlando, Fla.) 2008 Mar;126(3):251-9
Inhibition of c-Jun N-terminal kinase rescues influenza epitope-specific human cytolytic T lymphocytes from activation-induced cell death. Mehrotra, Shikhar; Chhabra, Arvind; Hegde, Upendra; Chakraborty, Nitya G; Mukherji, Bijay Journal of leukocyte biology 2007 Feb;81(2):539-47
Activation-induced cell death of human melanoma specific cytotoxic T lymphocytes is mediated by apoptosis-inducing factor. Chhabra, Arvind; Mehrotra, Shikhar; Chakraborty, Nitya G; Dorsky, David I; Mukherji, Bijay European journal of immunology 2006 Dec;36(12):3167-74
Effect of CD4+CD25+ and CD4+CD25- T regulatory cells on the generation of cytolytic T cell response to a self but human tumor-associated epitope in vitro. Chattopadhyay, Subhasis; Mehrotra, Shikhar; Chhabra, Arvind; Hegde, Upendra; Mukherji, Bijay; Chakraborty, Nitya G Journal of immunology (Baltimore, Md. : 1950) 2006 Jan;176(2):984-90
Macrophages as stimulators of MART-1 27-35 epitope-specific human cytolytic T lymphocytes in vitro. Mehrotra, Shikhar; Zaidi, Nisar; Chakraborty, Nitya G; Mukherji, Bijay Pathobiology : journal of immunopathology, molecular and cellular biology 2006 Jan;73(5):238-43
Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells. Mehrotra, Shikhar; Chhabra, Arvind; Chakraborty, Abolokita; Chattopadhyay, Subhasis; Slowik, Mark; Stevens, Robert; Zengou, Ryan; Mathias, Clinton; Butterfield, Lisa H; Dorsky, David I; Economou, James S; Mukherji, Bijay; Chakraborty, Nitya G Immunology 2004 Dec;113(4):472-81
Rescuing melanoma epitope-specific cytolytic T lymphocytes from activation-induced cell death, by SP600125, an inhibitor of JNK: implications in cancer immunotherapy. Mehrotra, Shikhar; Chhabra, Arvind; Chattopadhyay, Subhasis; Dorsky, David I; Chakraborty, Nitya G; Mukherji, Bijay Journal of immunology (Baltimore, Md. : 1950) 2004 Nov;173(10):6017-24
Cross-presentation of a human tumor antigen delivered to dendritic cells by HSV VP22-mediated protein translocation. Chhabra, Arvind; Mehrotra, Shikhar; Chakraborty, Nitya G; Mukherji, Bijay; Dorsky, David I European journal of immunology 2004 Oct;34(10):2824-33
Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma. Chakraborty, Nitya G; Chattopadhyay, Subhasis; Mehrotra, Shikhar; Chhabra, Arvind; Mukherji, Bijay Human immunology 2004 Aug;65(8):794-802
Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses. Schumacher, Lana; Ribas, Antoni; Dissette, Vivian B; McBride, William H; Mukherji, Bijay; Economou, James S; Butterfield, Lisa H Journal of immunotherapy (Hagerstown, Md. : 1997) 2004 Jan;27(3):191-200
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma. Butterfield, Lisa H; Ribas, Antoni; Dissette, Vivian B; Amarnani, Saral N; Vu, Huong T; Oseguera, Denise; Wang, He-Jing; Elashoff, Robert M; McBride, William H; Mukherji, Bijay; Cochran, Alistair J; Glaspy, John A; Economou, James S Clinical cancer research : an official journal of the American Association for Cancer Research 2003 Mar;9(3):998-1008
Stimulatory and inhibitory differentiation of human myeloid dendritic cells. Chakraborty, A; Li, L; Chakraborty, N G; Mukherji, B Clinical immunology (Orlando, Fla.) 2000 Feb;94(2):88-98
京公网安备 11010802027423号